Centro / Instituto vinculado a la Universidad de Navarra
Centro de Investigación de Medicina Aplicada (CIMA)
Publikationen (108) Publikationen, an denen Forscher/innen teilgenommen haben
2024
-
A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections
Cells, Vol. 13, Núm. 11
-
A mouse model to assess immunotherapy-related colitis
Methods in Cell Biology (Academic Press Inc.)
-
A road map for the treatment of pediatric diffuse midline glioma
Cancer Cell
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Agrypnia Excitata and Supranuclear Vertical Gaze Palsy Linked to Anti-Ma Encephalitis
Movement Disorders Clinical Practice, Vol. 11, Núm. 5, pp. 571-574
-
An atlas of cells in the human tonsil
Immunity, Vol. 57, Núm. 2, pp. 379-399.e18
-
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/ MINOVA Study)
Clinical Cancer Research, Vol. 30, Núm. 1, pp. 176-186
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
-
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
Clinical Cancer Research, Vol. 30, Núm. 10, pp. 2085-2096
-
Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases
Biomimetics, Vol. 9, Núm. 1
-
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report
Journal of Neurology
-
CALR but Not JAK2 Mutations Are Associated with an Overexpression of Retinoid X Receptor Alpha in Essential Thrombocythemia
Cancers, Vol. 16, Núm. 8
-
CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer
Molecular Therapy Nucleic Acids, Vol. 35, Núm. 2
-
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials
Nature Communications, Vol. 15, Núm. 1
-
Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry
STAR Protocols, Vol. 5, Núm. 1
-
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice
Molecular Therapy, Vol. 32, Núm. 3, pp. 722-733
-
Considering nutritional status to improve outcomes of patients treated by atezolizumab–bevacizumab for advanced hepatocellular carcinoma
Liver International
-
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax
Clinical Cancer Research, Vol. 30, Núm. 7, pp. 1319-1326
-
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-priming
Immunological Reviews, Vol. 321, Núm. 1, pp. 143-151
-
DNA electroporation in a vacuum: A “shocking” innovation for vaccines
Molecular Therapy Nucleic Acids